L H Miller|S L Hoffman - JoVE Visualize

Showing results (371-380 of 437) with videos related to

Pageof 44

Sort By:

Nature|May 5, 1988

A vaccine candidate from the sexual stage of human malaria that contains EGF-like domainsD C Kaslow, I A Quakyi, C Syin, et al.

Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1981

Monoclonal antibodies against a specific surface determinant on malarial (Plasmodium knowlesi) merozoites block erythrocyte invasionN Epstein, L H Miller, D C Kaushel, et al.

Science (New York, N.Y.)|June 2, 1989

Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytesS L Hoffman, D Isenbarger, G W Long, et al.

Science (New York, N.Y.)|October 28, 1988

Limited immunological recognition of critical malaria vaccine candidate antigensM F Good, L H Miller, S Kumar, et al.

The Journal of Biological Chemistry|October 15, 1990

A merozoite receptor protein from Plasmodium knowlesi is highly conserved and distributed throughout PlasmodiumA P Waters, A W Thomas, J A Deans, et al.

Science (New York, N.Y.)|April 24, 1987

Efficacy of murine malaria sporozoite vaccines: implications for human vaccine developmentJ E Egan, J L Weber, W R Ballou, et al.

The Journal of Infectious Diseases|October 1, 1995

Impact of transmission intensity and age on Plasmodium falciparum density and associated fever: implications for malaria vaccine trial designC Beadle, P D McElroy, C N Oster, et al.

Vaccine|March 1, 1997

Potent immunogenic short linear peptide constructs composed of B cell epitopes and Pan DR T helper epitopes (PADRE) for antibody responses in vivoM F del Guercio, J Alexander, R T Kubo, et al.

Lancet (London, England)|June 6, 1987

Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccineW R Ballou, S L Hoffman, J A Sherwood, et al.

Cancer Treatment Reports|January 1, 1987

Addition of etoposide to cyclophosphamide, doxorubicin, and vincristine for remission induction and survival in patients with small cell lung cancerA A Messeih, J M Schweitzer, A Lipton, et al.

Pageof 44

Showing results (371-380 of 437) with videos related to

Sort By:

Pageof 44

Nature|May 5, 1988

A vaccine candidate from the sexual stage of human malaria that contains EGF-like domainsD C Kaslow, I A Quakyi, C Syin, et al.

Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1981

Monoclonal antibodies against a specific surface determinant on malarial (Plasmodium knowlesi) merozoites block erythrocyte invasionN Epstein, L H Miller, D C Kaushel, et al.

Science (New York, N.Y.)|June 2, 1989

Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytesS L Hoffman, D Isenbarger, G W Long, et al.

Science (New York, N.Y.)|October 28, 1988

Limited immunological recognition of critical malaria vaccine candidate antigensM F Good, L H Miller, S Kumar, et al.

The Journal of Biological Chemistry|October 15, 1990

A merozoite receptor protein from Plasmodium knowlesi is highly conserved and distributed throughout PlasmodiumA P Waters, A W Thomas, J A Deans, et al.

Science (New York, N.Y.)|April 24, 1987

Efficacy of murine malaria sporozoite vaccines: implications for human vaccine developmentJ E Egan, J L Weber, W R Ballou, et al.

The Journal of Infectious Diseases|October 1, 1995

Impact of transmission intensity and age on Plasmodium falciparum density and associated fever: implications for malaria vaccine trial designC Beadle, P D McElroy, C N Oster, et al.

Vaccine|March 1, 1997

Potent immunogenic short linear peptide constructs composed of B cell epitopes and Pan DR T helper epitopes (PADRE) for antibody responses in vivoM F del Guercio, J Alexander, R T Kubo, et al.

Lancet (London, England)|June 6, 1987

Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccineW R Ballou, S L Hoffman, J A Sherwood, et al.

Cancer Treatment Reports|January 1, 1987

Addition of etoposide to cyclophosphamide, doxorubicin, and vincristine for remission induction and survival in patients with small cell lung cancerA A Messeih, J M Schweitzer, A Lipton, et al.

Pageof 44